In this investing video, Champion Shares PRO portfolio manager Nathan Parmelee discusses GlaxoSmithKline‘s (LSE: GSK) decision to make its dividend payout the top priority and how that might lower its long-term growth potential.
Is GlaxoSmithKline plc Making A Mistake By Prioritising The Dividend?
VIDEO: One Fool takes a closer look at GlaxoSmithKline plc (LON:GSK)
Posted by
Published Nathan is the most senior member of the Fool's global equities research team, having written for the Fool since 2004 and serving as co-advisor of Motley Fool Global Gains since 2008.
Before coming to the Fool, Nathan worked for a well-regarded industrial and financial services company, where he learned the intricacies of corporate acquisitions. His previous life allowed him to see the world -- including a three-year stint in Japan -- but ultimately, it was not his passion. He feels much more at ease evaluating potential investments for Foolish readers.
Nathan's investing interests include consumer goods, energy, agriculture, and special situations.
The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.
